Northern Trust Company of Connecticut’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Northern Trust Company of Connecticut’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$934K	Buy	+36,282	New	+$882K	0.01%	1376

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Northern Trust Company of Connecticut's PTLA Position: Q4 2013 in Review

Northern Trust Company of Connecticut opened a new position in Portola Pharmaceuticals, Inc. (PTLA) in Q4 2013: 36,282 shares worth $934K. The stake represents 0.01% of the portfolio and ranks #1376 among its holdings.

92 funds tracked by Wall St. Rank hold PTLA as of Q4 2013.

Northern Trust Company of Connecticut held 36,282 shares of Portola Pharmaceuticals, Inc. worth $934K as of Q4 2013.
Portola Pharmaceuticals, Inc. was a new Northern Trust Company of Connecticut position in Q4 2013.
Portola Pharmaceuticals, Inc. made up 0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1376 holding.
92 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.